HYDERABAD: Aurobindo Pharma on Wednesday informed the bourses ... The USFDA, which inspected the facility at Parawada in Anakapalli district of Andhra Pradesh from March 28, 2024, to April 5 ...

Aurobindo's manufacturing operations have once again landed the Indian drugmaker in hot water with the U.S. FDA. | ...

Generic Xarelto is a blood thinner medicine that lowers blood clotting. Aurobindo has obtained the Food and Drug ...

Aurobindo Pharma on March 28, in a regulatory filing, announced that it has acquired the business and certain assets of Veritaz Healthcare for cash consideration of Rs 171 crore. "The transaction ...